# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# NCT04434872

# Study name

Fecal microbiota transplantation as a treatment for ulcerative colitis

# Methods

RCT conducted in Israel

# Participants

# Inclusion criteria

- Ages 18–70 years
- Diagnosis of UC for > 3 months
- Active colitis disease with endoscopic score > 0
- Ability to sign an informed consent

# Exclusion criteria

- Acute neutrophilia (&lt; 500 neutrophils/μL)
- Severe immunodeficiency
- Clostridioides difficile infection
- Exposure to antibiotics in previous 2 weeks
- Hospitalization
- Proctitis involving &lt; 10 cm of rectum
- Malignancy within past 5 years (excluding basal cell carcinoma)
- Unstable dose of steroids or 5-ASA within past 2 weeks or immunomodulator and biologic therapy within past 12 weeks

# Interventions

# Experimental arm

Donor-based FMT once via colonoscopy (250 mL), then 3 more times via either nasojejunal tube or enema (100 mL each), depending on extent of disease

# Control arm

Autologous FMT once via colonoscopy (250 mL), then 3 more times via either nasojejunal tube or enema (100 mL each), depending on extent of disease

# Outcomes

# Primary outcome

Clinical improvement at week 8, defined by SCCAI and Mayo score

# Secondary outcomes

- Histologic remission at week 8, based on sigmoidoscopy assessment
- Long-term remission after 1 year, based on questionnaires

# Starting date

# Contact information

# Notes

Study was terminated due to lack of budget

# NCT04521205

# Study name

A multicenter clinical trial: efficacy, safety of fecal microbiota transplantation for inflammatory bowel disease

# Methods

RCT conducted in China

# Participants

# Inclusion criteria

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.